All posts by: Michael Zand

About Michael Zand

‘Unsafe’ Stem-Cell Eye Injections Draw Rebuke, Prompt Settlements – Daily Business Review (registration)

Continue reading

2017-04-11 NEWS

Daily Business Review (registration)

‘Unsafe’ StemCell Eye Injections Draw Rebuke, Prompt Settlements
Daily Business Review (registration)
Coral Gables law firm Grossman Roth Yaffa Cohen filed lawsuits on behalf of the two patients, both over age 70, who traveled to Sunrise and paid $5,000 each for what they believed was stemcell therapy that would help with age-related vision loss.

and more »

Continue reading

2017-04-11 NEWS

Identifying a Novel Target for Cancer Immunotherapy
Northwestern University NewsCenter
Immunotherapy is a type of cancer treatment that stimulates the patient’s own immune system to attack cancer cells. One immunotherapy approach involves targeting a group of proteins, called immune checkpoints, that normally prevents the immune system …

Continue reading

2017-04-11 NEWS

Quest Management Inc. Signs Letter of Intent to Acquire Immunotherapy Biotech Company Stemvax, Inc
Yahoo Finance
MADONA, Latvia, April 11, 2017 (GLOBE NEWSWIRE) — Quest Management Inc. (QSMG) announces the signing of a Letter of Intent (the “Agreement”) to acquire immunotherapy Biotech company Stemvax, Inc., from Dr. Dwain Morris-Irvin PhD. Upon Closing …

and more »

Continue reading

2017-04-11 NEWS

Human Gene Therapy publishes review of randomized clinical trials of gene transfer for heart
PR Newswire (press release)
SAN DIEGO, April 11, 2017 /PRNewswire-USNewswire/ — Renova™ Therapeutics, a biotechnology company developing gene and peptide therapies for cardiovascular and metabolic diseases, today announced its co-founder’s online publication of an article …